Sun Pharma gets FDA approval for generic Keppra injection

Mumbai-based Sun Pharma Ltd said it received an abbreviated new drug application (ANDA) approval from US Food and Drug Administration (USFDA) to market its levetiracetam injection which is generic version of Keppra injection,.
This levetiracetam injection 100 mg/ml packaged in 500 mg/5ml single use vials is equivalent to UCB's Keppra injection 100 mg/ml. Annual sale in the US for levetiracetam injection is estimated at $85 million, Sun Pharma said in a regulatory filing.

Levetiracetam injection is used in adjunctive therapy for the treatment of partial onset seizures in adults with epilepsy. This injection is an alternative for patients when oral administration is temporarily not feasible.

On Thursday, Sun Pharma shares ended 0.6% down at Rs1,690 on the Bombay Stock Exchange, while the benchmark Sensex closed 0.88% up at 17,616 points.

User

Reliance Capital to buy 18% stake in Bloomberg UTV

Reliance Capital Ltd (RCL) said it has agreed to buy an 18% interest in Bloomberg UTV for an undisclosed amount. The investment will form part of RCL's exposure to the media sector, including inter alia its existing investment in the Network 18 Group and TV Today Network.

Bloomberg UTV is a strategic partnership between US-based Bloomberg LP and  India-based UTV. Upon receipt of necessary approvals presently underway, Bloomberg will own 15% of the company and the balance of 67% is controlled by the UTV founders.

On Thursday, RCL shares ended 0.9% up at Rs764 on the Bombay Stock Exchange, while the benchmark Sensex closed 0.9% up at 17,616 points.

User

INTERVIEW: “Supply, demand & prices must even out”

(ML): How do you see the real-estate industry after the slowdown?
Vijay Wadhwa (VW): After the slowdown, the correction in prices in good locations helped to kick off sales. As the situation improved, developers slowly increased the prices of the properties by 10%-15% to cover their losses. But a few of them spiked up the prices over 25% due to which they failed to report good sales figures.

ML: What did you learn during the slowdown? How did the Indian realty market face it?
(VW): There are three main elements that are affected in a downturn—supply, demand and prices. If any one of these elements goes awry, the industry slows down. As As the slowdown entered India, we decreased our property prices, and properties in good locations reported sales due to reduced prices.

ML: How did you survive in the recession?
(VW): We met our suppliers and contractors to work out a solution to the slowdown. We negotiated so that we had to pay only the labour charges upfront. At some sites, we slowed down our work a bit but did not stop it. The next thing we did was to asses our existing asset portfolio carefully. For example, we owned a club at Borivali (a Mumbai suburb). In January 2009, we demolished the club and launched ‘Aquaria Grande’, a residential project.

ML: Affordable housing was the trend during the slowdown and now the industry is looking at constructing high-end flats. Why did the affordable home segment vanish?
VW: In Mumbai, developers started affordable housing because they had to survive on cash flow during the recession. However, affordable housing in this city cannot be sustained because the land itself is very expensive. Many developers started selling properties in peripheral areas of Mumbai at Rs1,800 to Rs2,000 per square feet. If one is building a 22-storey building and if we consider the cost of construction, municipal taxes and architect’s fees—excluding the land cost—the cost of development won’t be less than Rs1,800 per square feet. Developers thought that they would average the losses with sale of other projects. But as the industry started reviving, they increased the prices of the same properties between 15%-20%.

User

We are listening!

Solve the equation and enter in the Captcha field.
  Loading...
Close

To continue


Please
Sign Up or Sign In
with

Email
Close

To continue


Please
Sign Up or Sign In
with

Email

BUY NOW

The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)